About FIBOTRADE
Overview
FIBOTRADE is a trading entity registered in China, established on February 4, 2020. The broker operates through its official website, fibotrade.co.
Our review found very limited public information about FIBOTRADE. The broker has no listed regulatory licenses from any known financial authority. The absence of regulatory oversight is a significant factor for traders to consider.
Regulation and Safety
FIBOTRADE does not hold any regulatory licenses from major financial regulators. According to our records, the broker is unregulated.
For traders, the lack of regulation means there is no external oversight ensuring fair trading practices or segregation of client funds. This elevates the risk profile of the broker.
Trading Platform and Instruments
Due to insufficient public information, we cannot verify the trading platforms or instruments offered by FIBOTRADE. The broker's website may provide details, but our review could not confirm them.
Traders should exercise caution and conduct thorough due diligence before engaging with this broker.
Account Types and Funding
Information regarding account types, minimum deposits, and funding methods is not available from independent sources. The broker's official site might list these details, but they are not verifiable through our research.
Without clear account terms, traders face uncertainty about trading conditions and costs.
Conclusion
FIBOTRADE is an unregulated broker based in China with limited public footprint. The lack of regulatory oversight and transparency are red flags.
Traders are advised to approach this broker with extreme caution and consider alternative, regulated brokers for their trading needs.
Overview compiled by FXCanary from regulatory records and public data. full FIBOTRADE review